Neuberger Berman Group’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
Other funds holding PCRX
Neuberger Berman Group's PCRX Position: Q3 2026 in Review
Neuberger Berman Group increased its Pacira BioSciences (PCRX) stake by 2.6% in Q3 2026, buying an estimated $6.96K and bringing the position to 10,680 shares worth $268K. The position accounts for ﹤0.01% of the portfolio, ranked #2037.
Neuberger Berman Group first reported a position in PCRX in Q2 2013 and has held it in 23 quarters since. The position peaked at $26.5M in Q3 2014. 258 funds tracked by Wall St. Rank hold PCRX as of Q3 2026.
- Neuberger Berman Group held 10,680 shares of Pacira BioSciences worth $268K as of Q3 2026.
- Neuberger Berman Group bought 275 Pacira BioSciences shares in Q3 2026, an estimated $6.96K.
- Pacira BioSciences made up ﹤0.01% of Neuberger Berman Group's portfolio in Q3 2026, its #2037 holding.
- Neuberger Berman Group first reported a position in Pacira BioSciences in Q2 2013 and has held it in 23 quarters since.
- Neuberger Berman Group's Pacira BioSciences position peaked at $26.5M in Q3 2014.
- 258 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2026.
Based on Neuberger Berman Group's 13F filing for Q3 2026, filed 13 Nov 2026.